Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2026 09:00 ET | Source: RenX Enterprises Corp.

RenX Enterprises Corp. Highlights Transformational Year with Expected $7 Million in Revenues during 2025, Operating Scale, and Debt Reduction

MIAMI, FL, Jan. 09, 2026 (GLOBE NEWSWIRE) -- RenX Enterprises Corp. (NASDAQ: RENX) (the “Company”) today provided an update on a year that management views as transformational, reflecting a...
January 09, 2026 09:00 ET | Source: CLOUDASTRUCTURE, INC.

Cloudastructure Launches AI-Powered Security Enclosure

PALO ALTO, CA, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Cloudastructure, Inc. (Nasdaq: CSAI) (“we,” “us,” “our,” “Cloudastructure” or the “Company”), a leader in AI-powered video surveillance and remote...
January 09, 2026 09:00 ET | Source: Oncolytics Biotech, Inc.

Oncolytics Biotech® Outlines Strategic Rationale for Proposal to Change Jurisdiction of Incorporation to Nevada

SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today provided...
January 09, 2026 09:00 ET | Source: SB Financial Group, Inc.

SB Financial Group, Inc. Announces Schedule for Fourth Quarter and Full Year 2025 Results

DEFIANCE, Ohio, Jan. 09, 2026 (GLOBE NEWSWIRE) -- SB Financial Group, Inc. (NASDAQ: SBFG), a diversified financial services company providing full-service community banking, mortgage banking, wealth...
January 09, 2026 09:00 ET | Source: Akari Therapeutics Plc

Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026

Access the Akari CEO Corner here TAMPA, Fla. and LONDON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payloads for...
January 09, 2026 08:55 ET | Source: Senti Biosciences, Inc.

Senti Bio to Participate in Panel Presentation at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene...
January 09, 2026 08:45 ET | Source: Autonomix Medical, Inc.

Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium

New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, including late-stage patients with otherwise limited treatment options THE...
January 09, 2026 08:45 ET | Source: PDS Biotechnology Corporation

PDS Biotech Announces FDA Alignment on use of Progression Free Survival (PFS) as Primary Endpoint

PDS Biotech Submits Amended Protocol for Phase 3 VERSATILE-003 Trial Constructive Type C Meeting Provides Potential Pathway to Accelerated Approval of PDS0101 PRINCETON, N.J., Jan. 09, 2026 (GLOBE...
January 09, 2026 08:30 ET | Source: Clene Inc.

Clene Announces Registered Direct Offering of Over $28 Million

Oversubscribed registered direct offering priced above market to new, existing and insider investors, including Boxer Capital Management, Coastlands Capital, and Vivo CapitalInitial financing tranche...
January 09, 2026 08:30 ET | Source: Perma-Fix Environmental Services, Inc

Perma-Fix Environmental Services Receives Expanded Permit for Richland Facility, Approximately Tripling Liquid Mixed Waste Processing Capacity

ATLANTA, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced that it has received a final Dangerous Mixed Waste Permit Renewal for...